ADVANCING ORAL CANCER DIAGNOSIS VIA TGFΒ SIGNALING PATHWAY

Main Article Content

Sidra Hasnain
Sana Javaid Awan
Sana Khurshid
Anam Farzand
Mubeen Shahzadi

Keywords

TGFβRII, ELISA, Transformation, TGFβ, Col2a1 and Oral cancer

Abstract

Background: The risk to a person's life posed by oral cancer can be significantly reduced if it is identified and confirmed early in the course of the illness. As a regulator, transforming growth factor-β (TGFβ) is essential to the control of numerous biological processes. Oral cancer patients' salivary TGFβ levels increase. It might therefore be applied as a diagnostic biomarker. The objective of this research was to create a reporter system in yeast cells that can identify TGFβ, serving as a non-invasive means of screening for oral cancer. Methodology: Transformation of yeast cells was verified by restriction digestion after transforming growth factor beta receptor II (TGFβRII) and collagen type II alpha chain I (col2a1) (intronic region) carrying vector were added. Gel electrophoresis analysis was used to express, optimise, and establish the recombinant proteins. Additionally, saliva from patients with oral cancer was combined with recombinant yeast cells, and the results were evaluated using green fluorescence protein fluorescence microscopy and the enzyme-linked immunosorbent assay (ELISA). Results: It was discovered that there was a substantial difference in TGFβ expression (P value < 0.05) between yeast cells that had undergone transformation and those that had not. Oral cancer patients' saliva samples were tested for TGFβ using ELISA, and samples of yeast treated with saliva were tested for TGFβ using solid-phase sandwich ELISA. The yeast samples containing TGFβRII and Col2a1 expression vectors showed the highest fluorescence. Conclusion: In this work, a green fluorescent protein reporter system based on yeast was developed for molecular detection of early oral cancer via saliva. ELISA and fluorescence microscopy were used to optimise and detect TGFβRII protein expression in S. cerevisiae. Oral cancer can be diagnosed non-invasively with this co-transformed method.

Abstract 214 | Pdf Downloads 76

References

1. Brückner, A., Polge, C., Lentze, N., Auerbach, D., & Schlattner, U. (2009). Yeast two-hybrid, a powerful tool for systems biology. International journal of molecular sciences, 10(6), 2763-2788.
2. Cheah, K., Stoker, N. G., Griffin, J. R., Grosveld, F. G., & Solomon, E. (1985). Identification and characterization of the human type II collagen gene (COL2A1). Proceedings of the National Academy of Sciences, 82(9), 2555-2559.
3. De la Vega, R. E., Scheu, M., Brown, L. A., Evans, C. H., Ferreira, E., & Porter, R. M. (2019). Specific, sensitive, and stable reporting of human mesenchymal stromal cell chondrogenesis. Tissue Engineering Part C: Methods, 25(3), 176-190.
4. Fields, S., & Song, O.-k. (1989). A novel genetic system to detect protein–protein interactions. Nature, 340(6230), 245-246.
5. Ghazi, N., Saghravanian, N., Shakeri, M. T., & Jamali, M. (2021). Evaluation of CD44 and TGF-B expression in oral carcinogenesis. Journal of Dentistry, 22(1), 33.
6. Gietz, R. D. (2014). Yeast transformation by the LiAc/SS carrier DNA/PEG method. Yeast Genetics: Methods and Protocols, 1-12.
7. Ishii, J., Kondo, T., Makino, H., Ogura, A., Matsuda, F., & Kondo, A. (2014). Three gene expression vector sets for concurrently expressing multiple genes in Saccharomyces cerevisiae. FEMS yeast research, 14(3), 399-411.
8. Kaishima, M., Ishii, J., Matsuno, T., Fukuda, N., & Kondo, A. (2016). Expression of varied GFPs in Saccharomyces cerevisiae: codon optimization yields stronger than expected expression and fluorescence intensity. Scientific reports, 6(1), 1-15.
9. Kan, A., Ikeda, T., Saito, T., Yano, F., Fukai, A., Hojo, H., . . . Chung, U. I. (2009). Screening of chondrogenic factors with a real‐time fluorescence‐monitoring cell line ATDC5‐C2ER: Identification of sorting nexin 19 as a novel factor. Arthritis & Rheumatism: Official Journal of the American College of Rheumatology, 60(11), 3314-3323.
10. Khurshid, Z., Zafar, M. S., Khan, R. S., Najeeb, S., Slowey, P. D., & Rehman, I. U. (2018). Role of salivary biomarkers in oral cancer detection. Advances in clinical chemistry, 86, 23-70.
11. Kwak, J. H., Kim, S. I., Kim, J. K., & Choi, M. E. (2008). BAT3 interacts with transforming growth factor-β (TGF-β) receptors and enhances TGF-β1-induced type I collagen expression in mesangial cells. Journal of Biological Chemistry, 283(28), 19816-19825.
12. Lafont, J., Poujade, F.-A., Pasdeloup, M., Neyret, P., & Mallein-Gerin, F. (2016). Hypoxia potentiates the BMP-2 driven COL2A1 stimulation in human articular chondrocytes via p38 MAPK. Osteoarthritis and cartilage, 24(5), 856-867.
13. Liu, J. H., Wei, S., Burnette, P. K., Gamero, A. M., Hutton, M., & Djeu, J. Y. (1999). Functional association of TGF-β receptor II with cyclin B. Oncogene, 18(1), 269-275.
14. Meng, X.-m., Nikolic-Paterson, D. J., & Lan, H. Y. (2016). TGF-β: the master regulator of fibrosis. Nature Reviews Nephrology, 12(6), 325-338.
15. Nickel, J., Ten Dijke, P., & Mueller, T. D. (2018). TGF-β family co-receptor function and signaling. Acta biochimica et biophysica Sinica, 50(1), 12-36.
16. Nikawa, J.-i. (1994). A cDNA encoding the human transforming growth factor β receptor suppresses the growth defect of a yeast mutant. Gene, 149(2), 367-372.
17. Ovchinnikov, D. A., Wan, Y., Coman, W. B., Pandit, P., Cooper-White, J. J., Herman, J. G., & Punyadeera, C. (2014). DNA methylation at the novel CpG sites in the promoter of MED15/PCQAP gene as a biomarker for head and neck cancers. Biomarker insights, 9, BMI. S16199.
18. Peng, H., Tan, L., Osaki, M., Zhan, Y., Ijiri, K., Tsuchimochi, K., . . . Grall, F. T. (2008). ESE‐1 is a potent repressor of type II collagen gene (COL2A1) transcription in human chondrocytes. Journal of cellular physiology, 215(2), 562-573.
19. Pylayeva-Gupta, Y. (2011). Activity-dependent validation of excitatory vs. inhibitory synapses by neuroligin-1 vs. neuroligin-2. Bone, 23, 1-7.
20. Ryan, O. W., Poddar, S., & Cate, J. H. (2016). Crispr–cas9 genome engineering in Saccharomyces cerevisiae cells. Cold Spring Harbor Protocols, 2016(6), pdb. prot086827.
21. SANTAMARiA, R., Gil, J. A., Mesas, J. M., & Martín, J. F. (1984). Characterization of an endogenous plasmid and development of cloning vectors and a transformation system in Brevibacterium lactofermentum. Microbiology, 130(9), 2237-2246.
22. Schmidt, H., Kulasinghe, A., Perry, C., Nelson, C., & Punyadeera, C. (2016). A liquid biopsy for head and neck cancers. Expert review of molecular diagnostics, 16(2), 165-172.
23. Tan Timur, U., Caron, M., van den Akker, G., van der Windt, A., Visser, J., van Rhijn, L., . . . Jahr, H. (2019). Increased TGF-β and BMP levels and improved chondrocyte-specific marker expression in vitro under cartilage-specific physiological osmolarity. International journal of molecular sciences, 20(4), 795.
24. Vander Ark, A., Cao, J., & Li, X. (2018). TGF-β receptors: In and beyond TGF-β signaling. Cellular signalling, 52, 112-120.
25. Wajid, N., Naseem, R., Anwar, S. S., Awan, S. J., Ali, M., Javed, S., & Ali, F. (2015). The effect of gestational diabetes on proliferation capacity and viability of human umbilical cord-derived stromal cells. Cell and tissue banking, 16, 389-397.